To the Editor Drs Joyner and Paneth1 questioned the value of personalized medicine. We believe that they have selectively cited studies supporting their views and ignored contrary data.
The authors questioned whether the human genome contributes to disease risk prediction and concluded, based on 1 study, that genomic risk information does not improve patient outcomes. They did not discuss genes that predict risk for colon and other cancers, coronary artery disease, or neurodevelopmental conditions.
Dunnenberger HM, Khandekar JD. Value of Personalized Medicine. JAMA. 2016;315(6):612–613. doi:10.1001/jama.2015.17130